This grant supports investigator-initiated original research in all aspects of blood banking, transfusion medicine, and biotherapies. It prioritizes innovative projects by early-career investigators worldwide who have completed terminal training within 10 years and have not received substantial prior funding. The grants provide seed funding to enhance preliminary data and are awarded annually based on scientific merit and impact.
Eligible applicants are early-career investigators worldwide with an MD, PhD, medical technologist, or transfusion medicine/biotherapies background. They must have completed terminal training within 10 years and not have received a substantial research grant like an NIH R01.
